These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38001904)

  • 61. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors.
    Bossi P; Ascierto PA; Basset-Seguin N; Dreno B; Dummer R; Hauschild A; Mohr P; Kaufmann R; Pellacani G; Puig S; Moreno-Ramírez D; Robert C; Stratigos A; Gutzmer R; Queirolo P; Quaglino P; Peris K
    Crit Rev Oncol Hematol; 2023 Sep; 189():104066. PubMed ID: 37442495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experience with sonidegib in patients with advanced basal cell carcinoma: case reports.
    Puig S; Serra-Guillén C; Pérez-Pastor G; Martínez-Domenech Á; Fernández-de-Misa Cabrera R
    Drugs Context; 2022; 11():. PubMed ID: 35677182
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need?
    Moujaess E; Merhy R; Kattan J; Sarkis AS; Tomb R
    Immunotherapy; 2021 Oct; 13(15):1293-1304. PubMed ID: 34463126
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma.
    Buquicchio R; Mastrandrea V; Strippoli S; Quaresmini D; Guida M; Filotico R
    Front Oncol; 2021; 11():691980. PubMed ID: 34540666
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hedgehog pathway inhibitor real-world treatment patterns in patients with basal cell carcinoma: a claims-based analysis.
    Ge W; Chen CI; Wu N; Fury MG; Ruiz E; Jalbert JJ
    Future Oncol; 2022 Jul; 18(23):2561-2572. PubMed ID: 35735026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
    Ascierto PA; Schadendorf D
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas.
    Jain S; Song R; Xie J
    Onco Targets Ther; 2017; 10():1645-1653. PubMed ID: 28352196
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.
    Leavitt E; Lask G; Martin S
    Curr Treat Options Oncol; 2019 Nov; 20(11):84. PubMed ID: 31773379
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report.
    Ruggiero A; Lauro W; Miano C; Villani A; Fabbrocini G; Marasca C
    Case Rep Dermatol; 2023; 15(1):35-39. PubMed ID: 36817850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How to spot a basosquamous carcinoma: a study on demographics, clinical-dermatoscopic features and histopathological correlations.
    Sgouros D; Apalla Z; Theofili M; Damaskou V; Kokkalis G; Kitsiou E; Lallas A; Kanelleas A; Stratigos A; Nikolaidou C; Bobos M; Panayiotides I; Rigopoulos D; Katoulis A
    Eur J Dermatol; 2021 Dec; 31(6):779-784. PubMed ID: 34933836
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios.
    Akhtar K; Sravanthi MV; D'Angelo J; Sivapiragasam A
    J Investig Med High Impact Case Rep; 2022; 10():23247096221121408. PubMed ID: 36017984
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Basosquamous carcinoma: treatment with Mohs micrographic surgery.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    Cancer; 2005 Jul; 104(1):170-5. PubMed ID: 15929123
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients.
    DeTemple VK; Hassel JC; Sachse MM; Grimmelmann I; Leiter U; Gebhardt C; Eckardt J; Pföhler C; Angela Y; Hübbe H; Gutzmer R
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Perianal basosquamous carcinoma treated with radiation therapy, a case report.
    Kwan SY; Castillo DR; Aka AA; Kandala G; Tsai JY; Zmaj K; Reeves ME; Yang GY
    J Gastrointest Oncol; 2023 Feb; 14(1):463-467. PubMed ID: 36915436
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effective Management of Nasal Vestibule Squamous Cell Carcinoma with Cemiplimab: A Case Report.
    Costabile F; Donnarumma M; Piscosquito A; Ingenito C; Iuliucci MR; Buonerba C; Di Lorenzo G; Di Trolio R
    Case Rep Oncol; 2023; 16(1):935-938. PubMed ID: 37900804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.
    Lacouture ME; Dréno B; Ascierto PA; Dummer R; Basset-Seguin N; Fife K; Ernst S; Licitra L; Neves RI; Peris K; Puig S; Sokolof J; Sekulic A; Hauschild A; Kunstfeld R
    Oncologist; 2016 Oct; 21(10):1218-1229. PubMed ID: 27511905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hedgehog Pathway Inhibitors: Clinical Implications and Resistance in the Treatment of Basal Cell Carcinoma.
    Habashy S; Jafri A; Osman HO; Thomas NE; Udekwe S; Heindl SE
    Cureus; 2021 Mar; 13(3):e13859. PubMed ID: 33754119
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab].
    Delaitre L; Martins-Héricher J; Truchot E; Denis D; Prophette B; Maillard H; Bénéton-Benhard N
    Ann Dermatol Venereol; 2020 Apr; 147(4):279-284. PubMed ID: 31879092
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous Carcinoma.
    N Sivrikoz O; Kandiloğlu G
    Iran J Pathol; 2015; 10(3):185-91. PubMed ID: 26351483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.